nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—PTGS1—malignant glioma	0.564	1	CbGaD
Eletriptan—HTR1D—meninx—malignant glioma	0.0232	0.151	CbGeAlD
Eletriptan—HTR1B—dura mater—malignant glioma	0.022	0.143	CbGeAlD
Eletriptan—HTR1D—dura mater—malignant glioma	0.0213	0.139	CbGeAlD
Eletriptan—HTR1B—telencephalic ventricle—malignant glioma	0.00549	0.0357	CbGeAlD
Eletriptan—HTR1D—telencephalic ventricle—malignant glioma	0.00531	0.0346	CbGeAlD
Eletriptan—HTR7—pons—malignant glioma	0.00514	0.0335	CbGeAlD
Eletriptan—Vasospasm—Carmustine—malignant glioma	0.00451	0.0249	CcSEcCtD
Eletriptan—HTR1A—telencephalic ventricle—malignant glioma	0.00443	0.0288	CbGeAlD
Eletriptan—Hemiplegia—Carmustine—malignant glioma	0.00432	0.0238	CcSEcCtD
Eletriptan—HTR7—telencephalic ventricle—malignant glioma	0.00423	0.0275	CbGeAlD
Eletriptan—Hemiplegia—Temozolomide—malignant glioma	0.00417	0.023	CcSEcCtD
Eletriptan—HTR1F—telencephalon—malignant glioma	0.00322	0.0209	CbGeAlD
Eletriptan—HTR1E—brainstem—malignant glioma	0.00314	0.0204	CbGeAlD
Eletriptan—HTR1E—telencephalon—malignant glioma	0.00279	0.0181	CbGeAlD
Eletriptan—HTR1B—blood vessel—malignant glioma	0.00272	0.0177	CbGeAlD
Eletriptan—HTR1D—blood vessel—malignant glioma	0.00263	0.0171	CbGeAlD
Eletriptan—Myasthenia—Carmustine—malignant glioma	0.00245	0.0136	CcSEcCtD
Eletriptan—Aphasia—Carmustine—malignant glioma	0.00238	0.0131	CcSEcCtD
Eletriptan—Parosmia—Temozolomide—malignant glioma	0.0023	0.0127	CcSEcCtD
Eletriptan—Aphasia—Temozolomide—malignant glioma	0.0023	0.0127	CcSEcCtD
Eletriptan—Tooth disorder—Temozolomide—malignant glioma	0.0023	0.0127	CcSEcCtD
Eletriptan—Hypokinesia—Carmustine—malignant glioma	0.00228	0.0126	CcSEcCtD
Eletriptan—HTR7—endothelium—malignant glioma	0.00227	0.0148	CbGeAlD
Eletriptan—Burning sensation—Carmustine—malignant glioma	0.00222	0.0123	CcSEcCtD
Eletriptan—Myopathy—Temozolomide—malignant glioma	0.00212	0.0117	CcSEcCtD
Eletriptan—HTR7—blood vessel—malignant glioma	0.00209	0.0136	CbGeAlD
Eletriptan—Apathy—Temozolomide—malignant glioma	0.00209	0.0115	CcSEcCtD
Eletriptan—Flat affect—Temozolomide—malignant glioma	0.00207	0.0114	CcSEcCtD
Eletriptan—Stupor—Carmustine—malignant glioma	0.00207	0.0114	CcSEcCtD
Eletriptan—Menorrhagia—Temozolomide—malignant glioma	0.00201	0.0111	CcSEcCtD
Eletriptan—Abscess—Carmustine—malignant glioma	0.00195	0.0108	CcSEcCtD
Eletriptan—Otitis media—Temozolomide—malignant glioma	0.00191	0.0106	CcSEcCtD
Eletriptan—Hyperaesthesia—Temozolomide—malignant glioma	0.0019	0.0105	CcSEcCtD
Eletriptan—HTR1F—central nervous system—malignant glioma	0.00183	0.0119	CbGeAlD
Eletriptan—Speech disorder—Carmustine—malignant glioma	0.00179	0.0099	CcSEcCtD
Eletriptan—Accidental injury—Carmustine—malignant glioma	0.00174	0.00963	CcSEcCtD
Eletriptan—Speech disorder—Temozolomide—malignant glioma	0.00173	0.00957	CcSEcCtD
Eletriptan—Breast pain—Temozolomide—malignant glioma	0.00171	0.00943	CcSEcCtD
Eletriptan—Thinking abnormal—Carmustine—malignant glioma	0.00168	0.0093	CcSEcCtD
Eletriptan—Viral infection—Temozolomide—malignant glioma	0.00165	0.00911	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00164	0.00905	CcSEcCtD
Eletriptan—HTR1E—central nervous system—malignant glioma	0.00158	0.0103	CbGeAlD
Eletriptan—Gait disturbance—Carmustine—malignant glioma	0.00158	0.00873	CcSEcCtD
Eletriptan—Coordination abnormal—Carmustine—malignant glioma	0.00157	0.00867	CcSEcCtD
Eletriptan—PTGS1—endothelium—malignant glioma	0.00157	0.0102	CbGeAlD
Eletriptan—Gait disturbance—Temozolomide—malignant glioma	0.00153	0.00843	CcSEcCtD
Eletriptan—Coordination abnormal—Temozolomide—malignant glioma	0.00152	0.00838	CcSEcCtD
Eletriptan—Vaginal inflammation—Temozolomide—malignant glioma	0.00149	0.00823	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00149	0.00823	CcSEcCtD
Eletriptan—Depressed level of consciousness—Carmustine—malignant glioma	0.00149	0.00822	CcSEcCtD
Eletriptan—HTR1B—brainstem—malignant glioma	0.00148	0.00966	CbGeAlD
Eletriptan—Candida infection—Carmustine—malignant glioma	0.00147	0.00813	CcSEcCtD
Eletriptan—HTR1F—brain—malignant glioma	0.00145	0.00945	CbGeAlD
Eletriptan—PTGS1—blood vessel—malignant glioma	0.00145	0.00942	CbGeAlD
Eletriptan—Neuropathy—Carmustine—malignant glioma	0.00145	0.008	CcSEcCtD
Eletriptan—Depressed level of consciousness—Temozolomide—malignant glioma	0.00144	0.00795	CcSEcCtD
Eletriptan—HTR1D—brainstem—malignant glioma	0.00144	0.00936	CbGeAlD
Eletriptan—Candida infection—Temozolomide—malignant glioma	0.00142	0.00786	CcSEcCtD
Eletriptan—Vaginal infection—Temozolomide—malignant glioma	0.00141	0.00777	CcSEcCtD
Eletriptan—Neuropathy—Temozolomide—malignant glioma	0.0014	0.00773	CcSEcCtD
Eletriptan—Dry eye—Temozolomide—malignant glioma	0.00138	0.0076	CcSEcCtD
Eletriptan—Abnormal vision—Carmustine—malignant glioma	0.00134	0.00743	CcSEcCtD
Eletriptan—Mental disability—Carmustine—malignant glioma	0.00134	0.00739	CcSEcCtD
Eletriptan—HTR1B—telencephalon—malignant glioma	0.00132	0.00858	CbGeAlD
Eletriptan—Abnormal vision—Temozolomide—malignant glioma	0.0013	0.00718	CcSEcCtD
Eletriptan—Mental disability—Temozolomide—malignant glioma	0.00129	0.00714	CcSEcCtD
Eletriptan—Thrombophlebitis—Carmustine—malignant glioma	0.00129	0.00714	CcSEcCtD
Eletriptan—HTR1D—telencephalon—malignant glioma	0.00128	0.0083	CbGeAlD
Eletriptan—Ear pain—Temozolomide—malignant glioma	0.00127	0.007	CcSEcCtD
Eletriptan—HTR1E—brain—malignant glioma	0.00126	0.00818	CbGeAlD
Eletriptan—Thrombophlebitis—Temozolomide—malignant glioma	0.00125	0.0069	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00124	0.00687	CcSEcCtD
Eletriptan—Eye pain—Carmustine—malignant glioma	0.00124	0.00685	CcSEcCtD
Eletriptan—Injury—Carmustine—malignant glioma	0.00122	0.00673	CcSEcCtD
Eletriptan—Vascular purpura—Temozolomide—malignant glioma	0.00121	0.00668	CcSEcCtD
Eletriptan—HTR1A—brainstem—malignant glioma	0.0012	0.0078	CbGeAlD
Eletriptan—Eye pain—Temozolomide—malignant glioma	0.0012	0.00662	CcSEcCtD
Eletriptan—Amnesia—Carmustine—malignant glioma	0.00119	0.00658	CcSEcCtD
Eletriptan—HTR2B—telencephalon—malignant glioma	0.00119	0.00772	CbGeAlD
Eletriptan—Amnesia—Temozolomide—malignant glioma	0.00115	0.00636	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00115	0.00633	CcSEcCtD
Eletriptan—HTR7—brainstem—malignant glioma	0.00115	0.00745	CbGeAlD
Eletriptan—Thirst—Temozolomide—malignant glioma	0.00114	0.00628	CcSEcCtD
Eletriptan—Purpura—Temozolomide—malignant glioma	0.00112	0.0062	CcSEcCtD
Eletriptan—Diplopia—Carmustine—malignant glioma	0.00112	0.00618	CcSEcCtD
Eletriptan—Diplopia—Temozolomide—malignant glioma	0.00108	0.00597	CcSEcCtD
Eletriptan—Face oedema—Carmustine—malignant glioma	0.00108	0.00597	CcSEcCtD
Eletriptan—Affect lability—Temozolomide—malignant glioma	0.00106	0.00588	CcSEcCtD
Eletriptan—HTR1A—telencephalon—malignant glioma	0.00106	0.00692	CbGeAlD
Eletriptan—Ataxia—Carmustine—malignant glioma	0.00105	0.00581	CcSEcCtD
Eletriptan—Face oedema—Temozolomide—malignant glioma	0.00104	0.00577	CcSEcCtD
Eletriptan—Liver function test abnormal—Carmustine—malignant glioma	0.00103	0.00571	CcSEcCtD
Eletriptan—Mood swings—Temozolomide—malignant glioma	0.00102	0.00566	CcSEcCtD
Eletriptan—Ataxia—Temozolomide—malignant glioma	0.00102	0.00562	CcSEcCtD
Eletriptan—HTR7—telencephalon—malignant glioma	0.00102	0.00661	CbGeAlD
Eletriptan—Dry skin—Temozolomide—malignant glioma	0.000991	0.00548	CcSEcCtD
Eletriptan—Muscular weakness—Carmustine—malignant glioma	0.000987	0.00545	CcSEcCtD
Eletriptan—Dysphagia—Carmustine—malignant glioma	0.000967	0.00534	CcSEcCtD
Eletriptan—Muscular weakness—Temozolomide—malignant glioma	0.000954	0.00527	CcSEcCtD
Eletriptan—HTR1B—midbrain—malignant glioma	0.000946	0.00616	CbGeAlD
Eletriptan—Abdominal distension—Temozolomide—malignant glioma	0.000941	0.0052	CcSEcCtD
Eletriptan—Dysphagia—Temozolomide—malignant glioma	0.000935	0.00516	CcSEcCtD
Eletriptan—HTR1B—spinal cord—malignant glioma	0.000923	0.00601	CbGeAlD
Eletriptan—HTR1D—midbrain—malignant glioma	0.000916	0.00596	CbGeAlD
Eletriptan—Bronchitis—Temozolomide—malignant glioma	0.000899	0.00497	CcSEcCtD
Eletriptan—Hyperglycaemia—Carmustine—malignant glioma	0.000873	0.00482	CcSEcCtD
Eletriptan—Pollakiuria—Temozolomide—malignant glioma	0.000864	0.00477	CcSEcCtD
Eletriptan—Erectile dysfunction—Temozolomide—malignant glioma	0.000861	0.00476	CcSEcCtD
Eletriptan—CYP2A6—cerebellum—malignant glioma	0.000857	0.00558	CbGeAlD
Eletriptan—ABCB1—blood vessel—malignant glioma	0.000856	0.00557	CbGeAlD
Eletriptan—Weight increased—Temozolomide—malignant glioma	0.000851	0.0047	CcSEcCtD
Eletriptan—Weight decreased—Temozolomide—malignant glioma	0.000846	0.00467	CcSEcCtD
Eletriptan—Neuropathy peripheral—Carmustine—malignant glioma	0.000846	0.00467	CcSEcCtD
Eletriptan—Hyperglycaemia—Temozolomide—malignant glioma	0.000843	0.00466	CcSEcCtD
Eletriptan—Stomatitis—Carmustine—malignant glioma	0.000841	0.00464	CcSEcCtD
Eletriptan—Neuropathy peripheral—Temozolomide—malignant glioma	0.000817	0.00451	CcSEcCtD
Eletriptan—Stomatitis—Temozolomide—malignant glioma	0.000813	0.00449	CcSEcCtD
Eletriptan—HTR7—medulla oblongata—malignant glioma	0.000799	0.0052	CbGeAlD
Eletriptan—Sinusitis—Temozolomide—malignant glioma	0.000782	0.00432	CcSEcCtD
Eletriptan—Hypoaesthesia—Carmustine—malignant glioma	0.00077	0.00426	CcSEcCtD
Eletriptan—Hallucination—Carmustine—malignant glioma	0.00077	0.00426	CcSEcCtD
Eletriptan—HTR1A—midbrain—malignant glioma	0.000764	0.00497	CbGeAlD
Eletriptan—Oedema peripheral—Carmustine—malignant glioma	0.000763	0.00421	CcSEcCtD
Eletriptan—HTR1B—central nervous system—malignant glioma	0.000749	0.00487	CbGeAlD
Eletriptan—Visual impairment—Carmustine—malignant glioma	0.000746	0.00412	CcSEcCtD
Eletriptan—HTR1A—spinal cord—malignant glioma	0.000745	0.00485	CbGeAlD
Eletriptan—Hypoaesthesia—Temozolomide—malignant glioma	0.000745	0.00411	CcSEcCtD
Eletriptan—Hallucination—Temozolomide—malignant glioma	0.000745	0.00411	CcSEcCtD
Eletriptan—Pharyngitis—Temozolomide—malignant glioma	0.000743	0.0041	CcSEcCtD
Eletriptan—Urinary tract disorder—Temozolomide—malignant glioma	0.000739	0.00408	CcSEcCtD
Eletriptan—Oedema peripheral—Temozolomide—malignant glioma	0.000737	0.00407	CcSEcCtD
Eletriptan—Urethral disorder—Temozolomide—malignant glioma	0.000734	0.00405	CcSEcCtD
Eletriptan—HTR7—midbrain—malignant glioma	0.00073	0.00475	CbGeAlD
Eletriptan—HTR1D—central nervous system—malignant glioma	0.000725	0.00472	CbGeAlD
Eletriptan—Visual impairment—Temozolomide—malignant glioma	0.000721	0.00398	CcSEcCtD
Eletriptan—Flushing—Carmustine—malignant glioma	0.000719	0.00397	CcSEcCtD
Eletriptan—HTR7—spinal cord—malignant glioma	0.000712	0.00463	CbGeAlD
Eletriptan—PTGS1—telencephalon—malignant glioma	0.000702	0.00457	CbGeAlD
Eletriptan—Tinnitus—Temozolomide—malignant glioma	0.000698	0.00385	CcSEcCtD
Eletriptan—CYP2A6—brain—malignant glioma	0.000696	0.00453	CbGeAlD
Eletriptan—Flushing—Temozolomide—malignant glioma	0.000694	0.00384	CcSEcCtD
Eletriptan—Arrhythmia—Carmustine—malignant glioma	0.000692	0.00382	CcSEcCtD
Eletriptan—Alopecia—Carmustine—malignant glioma	0.000684	0.00378	CcSEcCtD
Eletriptan—Immune system disorder—Temozolomide—malignant glioma	0.000676	0.00373	CcSEcCtD
Eletriptan—HTR2B—central nervous system—malignant glioma	0.000675	0.00439	CbGeAlD
Eletriptan—Chills—Temozolomide—malignant glioma	0.000671	0.00371	CcSEcCtD
Eletriptan—Alopecia—Temozolomide—malignant glioma	0.000661	0.00365	CcSEcCtD
Eletriptan—Back pain—Carmustine—malignant glioma	0.000652	0.0036	CcSEcCtD
Eletriptan—CYP2D6—brainstem—malignant glioma	0.000651	0.00423	CbGeAlD
Eletriptan—Dysgeusia—Temozolomide—malignant glioma	0.000638	0.00352	CcSEcCtD
Eletriptan—Tremor—Carmustine—malignant glioma	0.000632	0.00349	CcSEcCtD
Eletriptan—Back pain—Temozolomide—malignant glioma	0.00063	0.00348	CcSEcCtD
Eletriptan—Anaemia—Carmustine—malignant glioma	0.000623	0.00344	CcSEcCtD
Eletriptan—Agitation—Carmustine—malignant glioma	0.000619	0.00342	CcSEcCtD
Eletriptan—Tremor—Temozolomide—malignant glioma	0.00061	0.00337	CcSEcCtD
Eletriptan—HTR1A—central nervous system—malignant glioma	0.000604	0.00393	CbGeAlD
Eletriptan—Ill-defined disorder—Temozolomide—malignant glioma	0.000604	0.00334	CcSEcCtD
Eletriptan—Leukopenia—Carmustine—malignant glioma	0.000603	0.00333	CcSEcCtD
Eletriptan—Anaemia—Temozolomide—malignant glioma	0.000602	0.00333	CcSEcCtD
Eletriptan—Agitation—Temozolomide—malignant glioma	0.000599	0.00331	CcSEcCtD
Eletriptan—Angioedema—Temozolomide—malignant glioma	0.000595	0.00329	CcSEcCtD
Eletriptan—HTR1B—brain—malignant glioma	0.000595	0.00387	CbGeAlD
Eletriptan—HTR1A—cerebellum—malignant glioma	0.000591	0.00384	CbGeAlD
Eletriptan—Malaise—Temozolomide—malignant glioma	0.000587	0.00324	CcSEcCtD
Eletriptan—Vertigo—Temozolomide—malignant glioma	0.000585	0.00323	CcSEcCtD
Eletriptan—Convulsion—Carmustine—malignant glioma	0.000584	0.00323	CcSEcCtD
Eletriptan—Leukopenia—Temozolomide—malignant glioma	0.000583	0.00322	CcSEcCtD
Eletriptan—Hypertension—Carmustine—malignant glioma	0.000582	0.00321	CcSEcCtD
Eletriptan—HTR7—central nervous system—malignant glioma	0.000578	0.00376	CbGeAlD
Eletriptan—CYP2D6—telencephalon—malignant glioma	0.000577	0.00376	CbGeAlD
Eletriptan—HTR1D—brain—malignant glioma	0.000576	0.00375	CbGeAlD
Eletriptan—Palpitations—Temozolomide—malignant glioma	0.000576	0.00318	CcSEcCtD
Eletriptan—Myalgia—Carmustine—malignant glioma	0.000574	0.00317	CcSEcCtD
Eletriptan—Anxiety—Carmustine—malignant glioma	0.000572	0.00316	CcSEcCtD
Eletriptan—Cough—Temozolomide—malignant glioma	0.000568	0.00314	CcSEcCtD
Eletriptan—HTR7—cerebellum—malignant glioma	0.000565	0.00367	CbGeAlD
Eletriptan—Convulsion—Temozolomide—malignant glioma	0.000564	0.00312	CcSEcCtD
Eletriptan—Hypertension—Temozolomide—malignant glioma	0.000562	0.00311	CcSEcCtD
Eletriptan—Confusional state—Carmustine—malignant glioma	0.000555	0.00306	CcSEcCtD
Eletriptan—Arthralgia—Temozolomide—malignant glioma	0.000555	0.00306	CcSEcCtD
Eletriptan—Myalgia—Temozolomide—malignant glioma	0.000555	0.00306	CcSEcCtD
Eletriptan—Anxiety—Temozolomide—malignant glioma	0.000553	0.00305	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000551	0.00304	CcSEcCtD
Eletriptan—Oedema—Carmustine—malignant glioma	0.00055	0.00304	CcSEcCtD
Eletriptan—Discomfort—Temozolomide—malignant glioma	0.000548	0.00303	CcSEcCtD
Eletriptan—Dry mouth—Temozolomide—malignant glioma	0.000542	0.003	CcSEcCtD
Eletriptan—Tachycardia—Carmustine—malignant glioma	0.000537	0.00297	CcSEcCtD
Eletriptan—Confusional state—Temozolomide—malignant glioma	0.000536	0.00296	CcSEcCtD
Eletriptan—HTR2B—brain—malignant glioma	0.000536	0.00349	CbGeAlD
Eletriptan—Oedema—Temozolomide—malignant glioma	0.000532	0.00294	CcSEcCtD
Eletriptan—Anorexia—Carmustine—malignant glioma	0.000524	0.0029	CcSEcCtD
Eletriptan—Nervous system disorder—Temozolomide—malignant glioma	0.000521	0.00288	CcSEcCtD
Eletriptan—Skin disorder—Temozolomide—malignant glioma	0.000516	0.00285	CcSEcCtD
Eletriptan—Hypotension—Carmustine—malignant glioma	0.000514	0.00284	CcSEcCtD
Eletriptan—Hyperhidrosis—Temozolomide—malignant glioma	0.000514	0.00284	CcSEcCtD
Eletriptan—ABCB1—embryo—malignant glioma	0.000511	0.00332	CbGeAlD
Eletriptan—Anorexia—Temozolomide—malignant glioma	0.000507	0.0028	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000501	0.00277	CcSEcCtD
Eletriptan—Insomnia—Carmustine—malignant glioma	0.000498	0.00275	CcSEcCtD
Eletriptan—Paraesthesia—Carmustine—malignant glioma	0.000494	0.00273	CcSEcCtD
Eletriptan—PTGS1—spinal cord—malignant glioma	0.000492	0.0032	CbGeAlD
Eletriptan—Dyspnoea—Carmustine—malignant glioma	0.00049	0.00271	CcSEcCtD
Eletriptan—Somnolence—Carmustine—malignant glioma	0.000489	0.0027	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000484	0.00268	CcSEcCtD
Eletriptan—Insomnia—Temozolomide—malignant glioma	0.000481	0.00266	CcSEcCtD
Eletriptan—HTR1A—brain—malignant glioma	0.00048	0.00312	CbGeAlD
Eletriptan—Decreased appetite—Carmustine—malignant glioma	0.000478	0.00264	CcSEcCtD
Eletriptan—Paraesthesia—Temozolomide—malignant glioma	0.000477	0.00264	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000475	0.00262	CcSEcCtD
Eletriptan—Dyspnoea—Temozolomide—malignant glioma	0.000474	0.00262	CcSEcCtD
Eletriptan—Somnolence—Temozolomide—malignant glioma	0.000473	0.00261	CcSEcCtD
Eletriptan—Constipation—Carmustine—malignant glioma	0.00047	0.0026	CcSEcCtD
Eletriptan—Pain—Carmustine—malignant glioma	0.00047	0.0026	CcSEcCtD
Eletriptan—Dyspepsia—Temozolomide—malignant glioma	0.000468	0.00258	CcSEcCtD
Eletriptan—Decreased appetite—Temozolomide—malignant glioma	0.000462	0.00255	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000459	0.00254	CcSEcCtD
Eletriptan—HTR7—brain—malignant glioma	0.000459	0.00298	CbGeAlD
Eletriptan—Fatigue—Temozolomide—malignant glioma	0.000458	0.00253	CcSEcCtD
Eletriptan—Constipation—Temozolomide—malignant glioma	0.000455	0.00251	CcSEcCtD
Eletriptan—Pain—Temozolomide—malignant glioma	0.000455	0.00251	CcSEcCtD
Eletriptan—Feeling abnormal—Carmustine—malignant glioma	0.000453	0.0025	CcSEcCtD
Eletriptan—ABCB1—retina—malignant glioma	0.000451	0.00294	CbGeAlD
Eletriptan—Gastrointestinal pain—Carmustine—malignant glioma	0.00045	0.00248	CcSEcCtD
Eletriptan—Feeling abnormal—Temozolomide—malignant glioma	0.000438	0.00242	CcSEcCtD
Eletriptan—Abdominal pain—Carmustine—malignant glioma	0.000435	0.0024	CcSEcCtD
Eletriptan—Body temperature increased—Carmustine—malignant glioma	0.000435	0.0024	CcSEcCtD
Eletriptan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000435	0.0024	CcSEcCtD
Eletriptan—Urticaria—Temozolomide—malignant glioma	0.000422	0.00233	CcSEcCtD
Eletriptan—Abdominal pain—Temozolomide—malignant glioma	0.00042	0.00232	CcSEcCtD
Eletriptan—Body temperature increased—Temozolomide—malignant glioma	0.00042	0.00232	CcSEcCtD
Eletriptan—ABCB1—telencephalon—malignant glioma	0.000415	0.0027	CbGeAlD
Eletriptan—Hypersensitivity—Carmustine—malignant glioma	0.000405	0.00224	CcSEcCtD
Eletriptan—PTGS1—central nervous system—malignant glioma	0.000399	0.0026	CbGeAlD
Eletriptan—Asthenia—Carmustine—malignant glioma	0.000395	0.00218	CcSEcCtD
Eletriptan—Hypersensitivity—Temozolomide—malignant glioma	0.000392	0.00216	CcSEcCtD
Eletriptan—Asthenia—Temozolomide—malignant glioma	0.000381	0.00211	CcSEcCtD
Eletriptan—Diarrhoea—Carmustine—malignant glioma	0.000376	0.00208	CcSEcCtD
Eletriptan—Pruritus—Temozolomide—malignant glioma	0.000376	0.00208	CcSEcCtD
Eletriptan—Dizziness—Carmustine—malignant glioma	0.000364	0.00201	CcSEcCtD
Eletriptan—Diarrhoea—Temozolomide—malignant glioma	0.000364	0.00201	CcSEcCtD
Eletriptan—Dizziness—Temozolomide—malignant glioma	0.000352	0.00194	CcSEcCtD
Eletriptan—Vomiting—Carmustine—malignant glioma	0.00035	0.00193	CcSEcCtD
Eletriptan—Rash—Carmustine—malignant glioma	0.000347	0.00192	CcSEcCtD
Eletriptan—Dermatitis—Carmustine—malignant glioma	0.000347	0.00191	CcSEcCtD
Eletriptan—Headache—Carmustine—malignant glioma	0.000345	0.0019	CcSEcCtD
Eletriptan—Vomiting—Temozolomide—malignant glioma	0.000338	0.00187	CcSEcCtD
Eletriptan—Rash—Temozolomide—malignant glioma	0.000335	0.00185	CcSEcCtD
Eletriptan—Dermatitis—Temozolomide—malignant glioma	0.000335	0.00185	CcSEcCtD
Eletriptan—CYP3A4—central nervous system—malignant glioma	0.000333	0.00217	CbGeAlD
Eletriptan—Headache—Temozolomide—malignant glioma	0.000333	0.00184	CcSEcCtD
Eletriptan—CYP2D6—central nervous system—malignant glioma	0.000328	0.00214	CbGeAlD
Eletriptan—Nausea—Carmustine—malignant glioma	0.000327	0.0018	CcSEcCtD
Eletriptan—ABCB1—medulla oblongata—malignant glioma	0.000326	0.00212	CbGeAlD
Eletriptan—CYP2D6—cerebellum—malignant glioma	0.000321	0.00209	CbGeAlD
Eletriptan—PTGS1—brain—malignant glioma	0.000317	0.00206	CbGeAlD
Eletriptan—Nausea—Temozolomide—malignant glioma	0.000316	0.00174	CcSEcCtD
Eletriptan—ABCB1—midbrain—malignant glioma	0.000298	0.00194	CbGeAlD
Eletriptan—ABCB1—spinal cord—malignant glioma	0.000291	0.00189	CbGeAlD
Eletriptan—CYP2D6—brain—malignant glioma	0.000261	0.0017	CbGeAlD
Eletriptan—ABCB1—central nervous system—malignant glioma	0.000236	0.00154	CbGeAlD
Eletriptan—ABCB1—cerebellum—malignant glioma	0.000231	0.0015	CbGeAlD
Eletriptan—ABCB1—brain—malignant glioma	0.000187	0.00122	CbGeAlD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—malignant glioma	1.26e-05	0.000124	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC5A5—malignant glioma	1.26e-05	0.000124	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CD—malignant glioma	1.26e-05	0.000124	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PIK3CA—malignant glioma	1.25e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—malignant glioma	1.25e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PIK3CA—malignant glioma	1.25e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KRAS—malignant glioma	1.24e-05	0.000122	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—malignant glioma	1.24e-05	0.000122	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PDGFB—malignant glioma	1.24e-05	0.000122	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CG—malignant glioma	1.23e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	1.23e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KRAS—malignant glioma	1.23e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—malignant glioma	1.23e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGFR1—malignant glioma	1.23e-05	0.000121	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.22e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	1.22e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FGF2—malignant glioma	1.21e-05	0.000119	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.21e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HIF1A—malignant glioma	1.21e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—malignant glioma	1.21e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FGF2—malignant glioma	1.2e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—malignant glioma	1.2e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT2—malignant glioma	1.2e-05	0.000119	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BCHE—malignant glioma	1.2e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—malignant glioma	1.2e-05	0.000118	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BCHE—malignant glioma	1.19e-05	0.000118	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARG—malignant glioma	1.19e-05	0.000117	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.19e-05	0.000117	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FGF2—malignant glioma	1.18e-05	0.000116	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.000116	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—IDH1—malignant glioma	1.18e-05	0.000116	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CAV1—malignant glioma	1.17e-05	0.000115	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.17e-05	0.000115	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.16e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—malignant glioma	1.16e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KDR—malignant glioma	1.16e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	1.16e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	1.15e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SPHK1—malignant glioma	1.14e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CA—malignant glioma	1.14e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—malignant glioma	1.14e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—malignant glioma	1.14e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MDM2—malignant glioma	1.13e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—malignant glioma	1.13e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CA—malignant glioma	1.13e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RAF1—malignant glioma	1.13e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MDM2—malignant glioma	1.13e-05	0.000111	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—malignant glioma	1.12e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RAF1—malignant glioma	1.12e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—malignant glioma	1.12e-05	0.00011	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.12e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FN1—malignant glioma	1.12e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—F2—malignant glioma	1.12e-05	0.00011	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.11e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—malignant glioma	1.11e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	1.11e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGF2—malignant glioma	1.11e-05	0.000109	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.1e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CB—malignant glioma	1.1e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MDM2—malignant glioma	1.1e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BAD—malignant glioma	1.1e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RAF1—malignant glioma	1.1e-05	0.000108	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CB—malignant glioma	1.1e-05	0.000108	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	1.09e-05	0.000107	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—malignant glioma	1.09e-05	0.000107	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CD—malignant glioma	1.08e-05	0.000107	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	1.07e-05	0.000106	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—malignant glioma	1.07e-05	0.000106	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD80—malignant glioma	1.07e-05	0.000105	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	1.07e-05	0.000105	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APC—malignant glioma	1.07e-05	0.000105	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—malignant glioma	1.06e-05	0.000104	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	0.000104	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGF—malignant glioma	1.05e-05	0.000104	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—malignant glioma	1.05e-05	0.000104	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTPN11—malignant glioma	1.05e-05	0.000103	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	1.05e-05	0.000103	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000103	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	1.04e-05	0.000102	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MDM2—malignant glioma	1.04e-05	0.000102	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RAF1—malignant glioma	1.03e-05	0.000102	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	0.000102	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.02e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—malignant glioma	1.02e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—malignant glioma	1.02e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	1.02e-05	0.0001	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—malignant glioma	1.02e-05	0.0001	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—malignant glioma	1.01e-05	0.0001	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAT—malignant glioma	1.01e-05	9.98e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—malignant glioma	1.01e-05	9.98e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—malignant glioma	1.01e-05	9.96e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	1.01e-05	9.93e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—malignant glioma	1.01e-05	9.93e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—malignant glioma	1.01e-05	9.92e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—malignant glioma	1e-05	9.88e-05	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	9.96e-06	9.81e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAT—malignant glioma	9.89e-06	9.74e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—malignant glioma	9.87e-06	9.72e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—malignant glioma	9.86e-06	9.71e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CA—malignant glioma	9.86e-06	9.71e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT2—malignant glioma	9.76e-06	9.62e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—malignant glioma	9.72e-06	9.58e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—malignant glioma	9.69e-06	9.54e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.63e-06	9.49e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—malignant glioma	9.59e-06	9.45e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—malignant glioma	9.58e-06	9.43e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NCOR1—malignant glioma	9.57e-06	9.43e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—malignant glioma	9.54e-06	9.39e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTEN—malignant glioma	9.53e-06	9.39e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—malignant glioma	9.53e-06	9.38e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—malignant glioma	9.5e-06	9.35e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—malignant glioma	9.47e-06	9.33e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CB—malignant glioma	9.44e-06	9.3e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	9.38e-06	9.24e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	9.36e-06	9.22e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—malignant glioma	9.36e-06	9.22e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NCOR1—malignant glioma	9.34e-06	9.2e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—malignant glioma	9.33e-06	9.19e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAT—malignant glioma	9.32e-06	9.18e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—malignant glioma	9.3e-06	9.16e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	9.29e-06	9.15e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—malignant glioma	9.28e-06	9.14e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—malignant glioma	9.27e-06	9.13e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—malignant glioma	9.26e-06	9.12e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—malignant glioma	9.24e-06	9.1e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAT—malignant glioma	9.24e-06	9.1e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—malignant glioma	9.18e-06	9.05e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—malignant glioma	9.05e-06	8.91e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—malignant glioma	9.04e-06	8.9e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGF2—malignant glioma	8.98e-06	8.85e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CB—malignant glioma	8.93e-06	8.8e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—malignant glioma	8.85e-06	8.72e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NCOR1—malignant glioma	8.8e-06	8.67e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—malignant glioma	8.76e-06	8.63e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NCOR1—malignant glioma	8.73e-06	8.59e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—malignant glioma	8.71e-06	8.58e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—malignant glioma	8.61e-06	8.48e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—malignant glioma	8.56e-06	8.43e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—malignant glioma	8.54e-06	8.41e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—malignant glioma	8.53e-06	8.4e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—malignant glioma	8.5e-06	8.37e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—malignant glioma	8.47e-06	8.34e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS1—malignant glioma	8.47e-06	8.34e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	8.44e-06	8.31e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MDM2—malignant glioma	8.4e-06	8.28e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—malignant glioma	8.38e-06	8.25e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAF1—malignant glioma	8.38e-06	8.25e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—malignant glioma	8.3e-06	8.17e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—malignant glioma	8.29e-06	8.16e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	8.18e-06	8.05e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—malignant glioma	8.16e-06	8.04e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—malignant glioma	8.05e-06	7.93e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—malignant glioma	7.92e-06	7.8e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—malignant glioma	7.87e-06	7.75e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—malignant glioma	7.87e-06	7.75e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—malignant glioma	7.87e-06	7.75e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—malignant glioma	7.86e-06	7.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAV1—malignant glioma	7.8e-06	7.68e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—malignant glioma	7.79e-06	7.67e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.77e-06	7.66e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—malignant glioma	7.75e-06	7.63e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—malignant glioma	7.72e-06	7.6e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—malignant glioma	7.71e-06	7.59e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—malignant glioma	7.7e-06	7.58e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAV1—malignant glioma	7.61e-06	7.5e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	7.59e-06	7.48e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—malignant glioma	7.54e-06	7.43e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—malignant glioma	7.52e-06	7.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—malignant glioma	7.51e-06	7.4e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.45e-06	7.34e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—malignant glioma	7.32e-06	7.21e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—malignant glioma	7.27e-06	7.16e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—malignant glioma	7.24e-06	7.13e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAV1—malignant glioma	7.18e-06	7.07e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—malignant glioma	7.12e-06	7.01e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAV1—malignant glioma	7.11e-06	7.01e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—malignant glioma	7.11e-06	7e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.11e-06	7e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—malignant glioma	7.08e-06	6.98e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—malignant glioma	7.07e-06	6.96e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CG—malignant glioma	6.94e-06	6.83e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—malignant glioma	6.89e-06	6.79e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—malignant glioma	6.86e-06	6.76e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.8e-06	6.69e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—malignant glioma	6.73e-06	6.63e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—malignant glioma	6.69e-06	6.59e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—malignant glioma	6.69e-06	6.59e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	6.68e-06	6.58e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	6.54e-06	6.44e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.54e-06	6.44e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—malignant glioma	6.51e-06	6.41e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.48e-06	6.38e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—malignant glioma	6.46e-06	6.37e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—malignant glioma	6.38e-06	6.29e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—malignant glioma	6.33e-06	6.23e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—malignant glioma	6.32e-06	6.22e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—malignant glioma	6.31e-06	6.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—malignant glioma	6.26e-06	6.17e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—malignant glioma	6.25e-06	6.16e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CD—malignant glioma	6.25e-06	6.15e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	6.15e-06	6.05e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CD—malignant glioma	6.1e-06	6.01e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAT—malignant glioma	6.09e-06	6e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—malignant glioma	5.95e-06	5.86e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—malignant glioma	5.87e-06	5.78e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—malignant glioma	5.76e-06	5.67e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NCOR1—malignant glioma	5.76e-06	5.67e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.75e-06	5.66e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—malignant glioma	5.74e-06	5.66e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.7e-06	5.61e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—malignant glioma	5.5e-06	5.41e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—malignant glioma	5.46e-06	5.38e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.45e-06	5.36e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—malignant glioma	5.44e-06	5.36e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—malignant glioma	5.43e-06	5.34e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—malignant glioma	5.4e-06	5.31e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—malignant glioma	5.35e-06	5.26e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CB—malignant glioma	5.31e-06	5.23e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—malignant glioma	5.27e-06	5.19e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—malignant glioma	5.02e-06	4.95e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.01e-06	4.93e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	4.98e-06	4.91e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.97e-06	4.89e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—malignant glioma	4.96e-06	4.89e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—malignant glioma	4.92e-06	4.85e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—malignant glioma	4.82e-06	4.75e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—malignant glioma	4.71e-06	4.63e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—malignant glioma	4.7e-06	4.63e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAV1—malignant glioma	4.69e-06	4.62e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—malignant glioma	4.59e-06	4.52e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—malignant glioma	4.45e-06	4.38e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—malignant glioma	4.33e-06	4.26e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—malignant glioma	4.29e-06	4.23e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.27e-06	4.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—malignant glioma	4.12e-06	4.06e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—malignant glioma	4.07e-06	4.01e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.76e-06	3.7e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.32e-06	3.27e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.27e-06	3.23e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—malignant glioma	3.24e-06	3.2e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—malignant glioma	3.24e-06	3.19e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.05e-06	3.01e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.03e-06	2.98e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—malignant glioma	2.83e-06	2.79e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—malignant glioma	2.71e-06	2.67e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—malignant glioma	2.65e-06	2.61e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—malignant glioma	2.49e-06	2.46e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—malignant glioma	2.47e-06	2.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—malignant glioma	2e-06	1.97e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—malignant glioma	1.63e-06	1.61e-05	CbGpPWpGaD
